Dr. Jeffrey D. Baumann, MD

Dr. Baumann practices at Mid Florida Eye Center PA in Mount Dora, Florida.

Dr. Baumann's NPI, 1841293974, was assigned on May 23, 2005. Dr. Baumann graduated from University of Miami, Miller School of Medicine in 1980. Dr. Baumann holds Florida license ME0045010.

Dr. Baumann's primary practice is Mid Florida Eye Center PA, at 17560 Us-441, Mount Dora, FL 32757 in Lake County. The practice phone is (352) 735-2020.

Dr. Baumann's primary practice is Mid Florida Eye Center PA in Mount Dora, Florida. Dmand AI also links Dr. Baumann to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baumann practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Baumann's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Baumann is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Baumann's licenses on file in 3 states: Florida, Louisiana and Alabama.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Baumann treats.

CMS data shows 3,730 Medicare services from Dr. Baumann across 20 procedure codes in 2024, for 1,059 Medicare patients. Medicare paid $286,347 for them.

CMS counts 1,059 Medicare patients who saw Dr. Baumann in 2024. The largest group is 75 to 84, with 539 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baumann's median patient age at 78, with 59% women.

In 2024, Dr. Baumann wrote 1,520 Medicare Part D claims for 437 patients. 61% of them were for generic drugs. CMS names the drug for 1,392 of them, across 20 drugs with 11 or more claims each, at $146,553 in total drug cost. In 2023, CMS named 1,888 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Baumann for performance year 2024, reported as part of a group. Dr. Baumann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 330 procedures of cataract surgery by Dr. Baumann, more than 91% of the clinicians it reports for that procedure.

Dmand AI links Dr. Baumann to 2 clinical trials. Conditions studied include Cataract, Presbyopia and Lens Diseases. Open Payments lists research payments to Dr. Baumann that name 1 trial.

CMS Open Payments shows 70 general payments to Dr. Baumann from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Alcon Laboratories Inc paid the most, $1,449. It also lists 21 research payments totaling $29,386 from 2016 to 2019, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Baumann, most recently CMS Stage 1 EHR in 2013.

Dr. Baumann graduated from University of Miami, Miller School of Medicine in 1980. Dr. Baumann is a member of AAO.

Dr. Baumann is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.